Liver‐directed drugs for transthyretin‐mediated amyloidosis

Transthyretin‐mediated amyloidosis (ATTR) is a rare, under‐recognized, progressively debilitating, fatal disease caused by the aggregation and extracellular deposition of amyloid transthyretin (TTR) fibrils in multiple organs and tissues throughout the body. TTR is predominantly synthesized by the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Brannagan, Thomas H., Berk, John L., Gillmore, Julian D., Maurer, Mathew S., Waddington‐Cruz, Márcia, Fontana, Marianna, Masri, Ahmad, Obici, Laura, Brambatti, Michela, Baker, Brenda F., Hannan, Lisa A., Buchele, Gustavo, Viney, Nick J., Coelho, Teresa, Nativi‐Nicolau, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100204/
https://www.ncbi.nlm.nih.gov/pubmed/36345805
http://dx.doi.org/10.1111/jns.12519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100204/
https://www.ncbi.nlm.nih.gov/pubmed/36345805
http://dx.doi.org/10.1111/jns.12519

Ejemplares similares